$74.65
▲ +0.4% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
USPH: Lowering target price to $67.00
How U.S. Physical Therapy’s (USPH) Clinic Acquisition Supports Its Outpatient Care Roll-Up Strategy
USPH: Raising target price to $65.00
Overview
52-week range
$58
$94
47% of range
Avg surprise (last 3)
+0.7%
Avg reaction (last 2)
+0.9%
50% positive
Latest IV / EM
58%
EM ±13.3% · $75 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $0.46 | $0.55 | -16.4% | -4.2% | +2.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.48 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $0.81 | $0.71 | +14.1% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.48 | $0.46 | +4.3% | — | -0.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.39 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.47 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.46 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.51 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.64 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | $0.85 | $0.81 | +4.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $198M | — | $197M | $197M | $184M | — | $168M | $167M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $33M | — | $37M | $42M | $31M | — | $29M | $34M |
| Operating income | $12M | — | $25M | $25M | $20M | — | $13M | $16M |
| Net income | $5M | — | $13M | $12M | $10M | — | $7M | $8M |
| EPS (diluted) | $-0.12 | — | $0.48 | $0.58 | $0.80 | — | $0.39 | $0.47 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $28M | $36M | $31M | $34M | $39M | $41M | $117M | $113M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $139M | $140M | $138M | $141M | $145M | $138M | $205M | $202M |
| Total assets | $1.24B | $1.20B | $1.20B | $1.18B | $1.18B | $1.17B | $1.03B | $1.02B |
| Long-term debt | $194M | $153M | $151M | $152M | $157M | $143M | $133M | $136M |
| Total liabilities | $459M | $434M | $414M | $414M | $421M | $408M | $358M | $353M |
| Total equity | $469M | $476M | $504M | $501M | $497M | $489M | $483M | $485M |